.AstraZeneca has actually shared a very early check out the performance of its own in-house antibody...
.After introducing a period 3 launch based upon beneficial midstage results, iTeos as well as GSK ar...
.The FDA needs to be a lot more open as well as collaborative to release a surge in commendations of...
.It is actually an abnormally active Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bic...
.Atea Pharmaceuticals' antiviral has actually stopped working yet another COVID-19 test, but the bio...
.Neurocrine Biosciences' mental illness plan pivot has failed. The biotech was actually not able to ...
.Sanofi has made a late entrance to the radioligand party, paying one hundred thousand europeans ($ ...
.After F2G's initial attempt to acquire a new class of antifungal to market was derailed by the FDA,...
.Moderna has pledged to cut R&D costs by $1.1 billion by 2027. The decision to retract the budget...
.Merely 4 months after Sanofi bet $80 million in beforehand cash on Key Therapeutics' losmapimod, th...